化合物Seralutinib T8900
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
2 mg | 1619931-27-9 | ¥598.00 | 询底价 |
100 mg | 1619931-27-9 | ¥5,550.00 | 询底价 |
1 mg | 1619931-27-9 | ¥412.00 | 询底价 |
50 mg | 1619931-27-9 | ¥3,480.00 | 询底价 |
25 mg | 1619931-27-9 | ¥2,650.00 | 询底价 |
10 mg | 1619931-27-9 | ¥1,490.00 | 询底价 |
1 mL | 1619931-27-9 | ¥987.00 | 询底价 |
5 mg | 1619931-27-9 | ¥993.00 | 询底价 |
Product Introduction
Bioactivity
英文名: Seralutinib
描述: Seralutinib (GB002) 是可吸入的PDGFRα 和 PDGFRβ激酶抑制剂,可用于研究肺动脉高压。
体内活性: GB002 dose- and time-dependently induces lung BMPR2 protein expression.GB002-mediated inhibition of lung PDGFRα/β phosphorylation in healthy Sprague Dawley rats immediately post inhalation[1].
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 100 mg/mL (212.98 mM)
关键字: PK 10571 | GB-002 | inhibit | arterial | PDGFR | PK10571 | GB 002 | PK-10571 | Seralutinib | PAH | Pulmonary | hypertension | Inhibitor | Platelet-derived growth factor receptor
相关产品: Ki20227 | R1530 | N-(p-Coumaroyl) serotonin | CP-673451 | Regorafenib | Tivozanib | Multi-kinase inhibitor 1 | Nintedanib esylate | Ponatinib | Lenvatinib
相关库: Drug Repurposing Compound Library | Anti-Cancer Drug Library | Clinical Compound Library | Membrane Protein-targeted Compound Library | Bioactive Compounds Library Max | Inhibitor Library | Kinase Inhibitor Library | Anti-Cancer Clinical Compound Library | Tyrosine Kinase Inhibitor Library | Reprogramming Compound Library
化合物Seralutinib T8900信息由TargetMol中国为您提供,如您想了解更多关于化合物Seralutinib T8900报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途